[1]
“The Efficacy of Infliximab Plus Methotrexate in Patients with Active Rheumatoid Arthritis in North of Iraq: 5 year Extended Study”, Adv.med.j., vol. 4, no. 1, pp. 6–10, Mar. 2023, doi: 10.56056/amj.2018.33.